The Zacks Analyst Blog Highlights: Theravance Biopharma, Krispy Kreme Doughnuts, Silicon Graphics International and Monotype Imaging Holdings

For Immediate Release

Chicago, IL – June 10, 2016 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Theravance Biopharma, Inc. (TBPH), Krispy Kreme Doughnuts, Inc. (KKD), Silicon Graphics International Corp. (SGI) and Monotype Imaging Holdings Inc. ( TYPE).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Thursday's Analyst Blog:

4 Stocks in Focus on New Analyst Coverage

Analysts play a crucial role in investment decisions as they hold vital information. A lack of information creates inefficiencies that might result in stocks being misrepresented (over- or under-valued).

Here two questions inevitably crop up. Do analysts create value for companies by initiating coverage? And, why do analysts initiate coverage?

Coverage initiation of a stock by analyst(s) usually depicts increased investor keenness. Investors, on their part, often assume there is something special in a stock to attract analysts to cover it. In other words, they believe that the company coming under the microscope definitely has some value.

Again, stocks are not randomly picked to cover. A new coverage on a stock is usually the result of a promising future envisioned by the analyst(s). At times, increased investors' focus on a stock motivates analysts to take a closer look at it. After all, who doesn't love to produce something that is already in demand?

One should also look for the average change in broker recommendation rather than a single recommendation change.

Analyst Coverage & Stock Price Movement

Interestingly, stocks typically see an upward price movement with a new analyst coverage compared to what they witness with a rating upgrade under an existing coverage. The price movement is a function of the recommendations from the new analysts. Positive recommendations – Buy and Strong Buy – generally lead to a significantly positive price reaction than Hold recommendations. In this regard, analysts hardly initiate coverage with a Strong Sell or Sell recommendation.

Now, if an analyst gives a new recommendation on a company that has very few or no existing coverage, investors start paying more attention to it. Also, any new information attracts portfolio managers to build a position in the stock.

So, it's a good strategy to bet on stocks that have seen increased analyst coverage over the last few weeks.

Screening Criteria:

Number of Broker Ratings now greater than the Number of Broker Ratings four weeks ago (This will shortlist stocks that have recent new coverage.)

Average Broker Rating less than Average Broker Rating four weeks ago ('Less than' means 'better than' four weeks ago.)

The number of increased analyst coverage and improving average rating are the primary criteria of this strategy, but one should consider other relevant parameters to make the strategy foolproof. Here are the other screening parameters:

Prices greater than or equal to 5 (as a stock below $5 will not likely create significant interest for most of the investors)

Average Daily Volume greater than or equal to 100,000 shares (if volume isn't enough, it will not attract individual investors).

Here are 4 stocks that passed the screen:

Theravance Biopharma, Inc. (TBPH) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas. With a number of data readouts lined up for the next few quarters, we expect investor focus to remain on pipeline updates from the company.

Krispy Kreme Doughnuts, Inc. (KKD), together with its subsidiaries, operates as a branded retailer and wholesaler of doughnuts, coffee and other complementary beverages, and treats and packaged sweets.

The company's first-quarter fiscal 2017 earnings were on par with the Street expectation and increased 4.2% year over year. Its revenues were also up 3% while system-wide store count rose 13.0% to 1,133 shops worldwide.

Silicon Graphics International Corp. (SGI) is a global leader in large-scale clustered computing, clustered storage, HPC and data center enablement and services. It reported better-than-expected fiscal third-quarter 2016 earnings. Although delays in the federal business are significantly impacting its outlook for the year, the company's growing High Performance Data Analytics or HPDA in-memory pipeline and new OEM deal are expected to help diversify and enhance its revenue and profitability.

Monotype Imaging Holdings Inc. (TYPE) provides text imaging solutions for manufacturers and developers of consumer electronics devices globally. The company delivered a solid first quarter, driven by a strong performance from its Creative Professional business. Its quarterly revenues increased 8% year over year.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today .

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.

This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
THERAVANCE BIO TBPH: Free Stock Analysis Report
 
KRISPY KREME KKD: Free Stock Analysis Report
 
SILICON GRAPHIC SGI: Free Stock Analysis Report
 
MONOTYPE IMAGNG TYPE: Free Stock Analysis Report
 
To read this article on Zacks.com click here.